Should pharmaceutical companies be compelled to waive their coronavirus vaccine patents?

The campaign to compel pharmaceutical companies to temporarily lift their coronavirus vaccine patents is gathering pace – and apparently making some progress. The momentum behind the campaign to remove intellectual property restrictions on Covid vaccines is growing. But would such a move really help defeat the pandemic more quickly?